Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Non-invasive MSOT Examination of Muscle Oxygenation in Athletes and PAD Patients

The aim of the study is to present the quantitative differences in oxygenated hemoglobin in different cohorts. This clinical study evaluates whether there is a correlation between measurements using multispectral optoacoustic tomography and the results of spiroergometry in the context of performance diagnostics.

Participants needed: 60
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: University Hospital ErlangenUpdated: Jan 16, 2026
Eligibility criteria

Age ≥ 18 years (adults capable of giving consent) [+6]

Age over 75 years [+5]

Status: Not yet recruiting

Diagnostic Imaging of Vascular Malformations Using MSOT and ULM

This clinical study evaluates the efficacy and accuracy of Multispectral Optoacoustic Tomography (MSOT) and Ultrasound Localization Microscopy (ULM) for imaging and diagnosing vascular malformations (venous, arteriovenous, lymphatic). The study aims to enhance diagnostic precision and improve treatment planning through advanced non-invasive imaging techniques.

Participants needed: 15
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital ErlangenUpdated: Jun 22, 2025Locations: 1
Eligibility criteria

Confirmed vascular malformations (arteriovenous, venous, or lymphatic). [+1]

No imaging for diagnostic confirmation has been performed or is planned. [+3]

Status: Recruiting

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.

Participants needed: 380
Trial details
Age: 15-25Biological sex: FemaleType: ObservationalSponsor: University Hospital ErlangenUpdated: Oct 15, 2024Locations: 1Duration: 1 Year
Eligibility criteria

Female subjects age 15-25 years [+1]

Less than 1 years from onset of menarche [+4]